Checkit
Ticker: CKT Exchange: AIM www.checkit.net

Checkit (formerly Elektron Technology) operates a SaaS platform that digitises and vastly improves the running of routine tasks/workflows, particularly with regards to efficiency, quality, standardisation and regulatory compliance.

In May’19, the group acquired Next Control Systems for £8.8m, with the ultimate aim of becoming a global powerhouse in real time operations management. Whilst simultaneously transitioning towards a pure 100% SaaS business across many sectors including Retail, Hospitality, Healthcare, Real Estate Management and Manufacturing.

There are 190 FTEs, and the firm is headquartered in Cambridge, UK with its Operations Centre in Fleet, and a Sales and Service office in California, US.

Taking Checkit to the ‘Next’ level

Visionary and founder of Apple, Steve Jobs, was a consummate genius at taking everyday concepts (ie PCs, mobile phones) and ultra-simplifying them for users. 

Likewise Checkit’s innovative SaaS solutions have transformed the process of completing routine tasks (eg cleaning restaurants, maintaining schools) - generating unrivalled benefits in terms of efficiency, customer service, repeatability, transparency, safety and regulatory compliance. 

The goal now is to exploit this 1st mover advantage, rapidly scale the division, and ultimately become a global ‘category champion’. This morning, the business took a major step forward towards achieving this objective, by announcing the £8.8m (cash/debt free) acquisition of Next Control Systems Ltd (NCS) – a leading UK (98% sales) remote monitoring, control, IoT and real time data analysis specialist, based in Fleet (Hampshire) and employing 104 staff.

The transaction is modestly priced (6.6x EV/EBITDA, 7.3x EV/EBIT), immediately earnings enhancing, value accretive, and should generate substantial synergies in due course. Not least, by improving product quality, up/x-selling services, expanding overseas and opening doors for Checkit into other non-food related verticals.

From a risk perspective too, all of NCS’ key employees have decided to stay on, which should ensure a smooth handover and integration. Plus, the deal appears to be relatively low risk, in light of the Board’s prior knowledge of the target, alongside the symbiotic chemistry, skillset and genetic fit.

Elsewhere, Q1’20 trading (ie Feb-April) has been strong, with turnover up 17% to £8.9m (LY £7.6m), driven primarily by Bulgin (+20%). Consequently, we have upgraded our FY20 and FY21 EBIT forecasts to £6.6m (vs £5.8m before) & £8.4m (£7.4m) respectively – but prudently held the 83p/share valuation. 

Download as a PDF file
26810392321 - checkit
Return to Checkit

Register to be first

Get research on the companies that interest you straight to your inbox

Register For Updates